Bullous pemphigoid: a review of its diagnosis, associations and treatment, Am J Clin Dermatol, vol.18, pp.513-541, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01825913
Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study, JAMA Dermatol, pp.25-33, 2014. ,
Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome. Sci Rep, vol.7, p.4833, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01825916
Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid, J Invest Dermatol, vol.134, pp.2908-2925, 2014. ,
Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome, Sci Rep, vol.5, p.18001, 2015. ,
Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes, J Allergy Clin Immunol, vol.139, pp.863-72, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01754072
NLRP3: a promising therapeutic target for autoimmune diseases, Autoimmun Rev, vol.17, pp.694-702, 2018. ,
IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells, J Exp Med, vol.210, pp.491-502, 2013. ,
Critical regulation of early Th17 cell differentiation by interleukin-1 signaling, Immunity, vol.30, pp.576-87, 2009. ,
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1? -dependent adaptive immunity against tumors, Nat Med, vol.15, pp.1170-1178, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00419823
Role of recombinant interleukin-1 compared to recombinant T-cell replacing factor/interleukin-5 in B-cell differentiation, Immunology, vol.63, pp.277-83, 1988. ,
Dangerassociated molecular patterns derived from the extracellular matrix provide temporal control of innate immunity, J Histochem Cytochem, vol.66, pp.213-240, 2018. ,
Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (Type XVII Collagen) in human bullous pemphigoid, J Invest Dermatol, vol.117, pp.1091-1097, 2001. ,
URL : https://hal.archives-ouvertes.fr/inserm-00153458
Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity, Br J Dermatol, vol.138, pp.611-615, 1998. ,
Increased expression of NLRP3 inflammasome components and interleukin-18 in patients with bullous pemphigoid, J Dermatol Sci, vol.83, pp.116-139, 2016. ,
Detection of IL-1 alpha, IL-1 beta and IL-1 receptor antagonist in blister fluid of bullous pemphigoid, J Dermatol Sci, vol.11, pp.142-149, 1996. ,
, Cytokine Gene Polymorphisms in Bullous Pemphigoid. Front Immunol, vol.10, p.636, 2019.
Activation and regulation of the inflammasomes, Nat Rev Immunol, vol.13, pp.397-411, 2013. ,
Inflammasome priming in sterile inflammatory disease, Trends Mol Med, vol.23, pp.165-80, 2017. ,
Redox control of NLRP3 inflammasome activation in health and disease, J Leukoc Biol, vol.92, pp.951-959, 2012. ,
IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1? by keratinocytes via the ROS-NLRP3-caspase-1 pathway, Int Immunol, vol.24, pp.147-58, 2012. ,
Interleukin-17A Induces IL-1? Secretion From RPE Cells Via the NLRP3 Inflammasome, Invest Ophthalmol Vis Sci, vol.57, pp.312-321, 2016. ,
Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes/macrophages, J Transl Med, vol.14, p.156, 2016. ,
Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group, Arch Dermatol, vol.134, pp.1075-80, 1998. ,
Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts, J Am Acad Dermatol, vol.66, pp.479-85, 2012. ,
Establishment and characterization of a human acute monocytic leukemia cell line (THP-1), Int J Cancer, vol.26, pp.171-177, 1980. ,
Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states, Nat Med, vol.23, pp.174-84, 2017. ,
The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis, Nat Immunol, vol.19, pp.1286-98, 2018. ,
Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules, J Immunol Baltim, vol.194, pp.3656-63, 2015. ,
NET formation in bullous pemphigoid patients with relapse is modulated by IL-17 and IL-23 interplay, Front Immunol, vol.10, p.701, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02274404
Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing, J Immunol Baltim, vol.161, pp.3340-3346, 1998. ,
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases, Nat Rev Drug Discov, vol.11, pp.633-52, 2012. ,